company background image
PDEX logo

Pro-Dex NasdaqCM:PDEX Voorraadrapport

Laatste prijs

US$31.34

Marktkapitalisatie

US$100.2m

7D

17.8%

1Y

100.3%

Bijgewerkt

01 Oct, 2024

Gegevens

Financiële gegevens bedrijf +

Pro-Dex, Inc.

NasdaqCM:PDEX Voorraadrapport

Marktkapitalisatie: US$100.2m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

PDEX Overzicht aandelen

Pro-Dex, Inc. ontwerpt, ontwikkelt, produceert en verkoopt wereldwijd chirurgische instrumenten met motor voor fabrikanten van medische apparatuur.

Over het bedrijf

Beloningen

Verhandeld tegen 26.9% onder onze schatting van de reële waarde
De winst zal naar verwachting met 42.82% per jaar groeien

Risicoanalyse

Grote eenmalige posten die de financiële resultaten beïnvloeden
Winstmarges (4%) zijn lager dan vorig jaar (15.3%)

Pro-Dex, Inc. Concurrenten

Sensus Healthcare

NasdaqCM:SRTS

US$95.1m

Kewaunee Scientific

NasdaqGM:KEQU

US$95.6m

Semler Scientific

NasdaqCM:SMLR

US$164.7m

Electromed

NYSEAM:ELMD

US$185.5m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Pro-Dex
Historische aandelenkoersen
Huidige aandelenkoersUS$31.34
52 Week HoogtepuntUS$31.95
52 Week LaagUS$14.51
Bèta0.38
11 maand verandering34.33%
3 maanden verandering82.95%
1 Jaar Verandering100.26%
33 jaar verandering21.47%
5 jaar verandering123.06%
Verandering sinds IPO476.36%

Recent nieuws en updates

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Sep 10
Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Recent updates

Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

Sep 10
Pro-Dex, Inc.'s (NASDAQ:PDEX) P/E Is Still On The Mark Following 37% Share Price Bounce

The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence

Jul 18
The Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire Confidence

Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Feb 16
Investors Can Find Comfort In Pro-Dex's (NASDAQ:PDEX) Earnings Quality

Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly

Feb 14
Here's Why Pro-Dex (NASDAQ:PDEX) Can Manage Its Debt Responsibly

Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Jan 24
Pro-Dex, Inc.'s (NASDAQ:PDEX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

May 20
Pro-Dex (NASDAQ:PDEX) Has A Pretty Healthy Balance Sheet

Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Oct 05
Pro-Dex (NASDAQ:PDEX) Could Be Struggling To Allocate Capital

Pro-Dex: Growth Trends In Earnings, Return On Investment Contracting

Sep 26

When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Sep 20
When Should You Buy Pro-Dex, Inc. (NASDAQ:PDEX)?

Pro-Dex GAAP EPS of $0.38, revenue of $12.61M

Aug 25

Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

May 10
Is Now The Time To Look At Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Apr 21
Is Pro-Dex (NASDAQ:PDEX) Using Too Much Debt?

Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Mar 14
Pro-Dex (NASDAQ:PDEX) Is Doing The Right Things To Multiply Its Share Price

Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

Feb 09
Is Pro-Dex, Inc. (NASDAQ:PDEX) Potentially Undervalued?

We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

Nov 17
We Think Pro-Dex (NASDAQ:PDEX) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

Aug 29
Is It Too Late To Consider Buying Pro-Dex, Inc. (NASDAQ:PDEX)?

A History Of Strong Growth Rates: Pro-Dex On Sale

Aug 25

The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising

May 18
The Return Trends At Pro-Dex (NASDAQ:PDEX) Look Promising

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Mar 29
What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 15
Is Weakness In Pro-Dex, Inc. (NASDAQ:PDEX) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted

Feb 26
The Pro-Dex (NASDAQ:PDEX) Share Price Is Up 732% And Shareholders Are Delighted

Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)

Feb 13
Independent Director William Farrell Just Sold A Bunch Of Shares In Pro-Dex, Inc. (NASDAQ:PDEX)

We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)

Feb 08
We Like These Underlying Trends At Pro-Dex (NASDAQ:PDEX)

Pro-Dex EPS misses by $0.27, misses on revenue

Feb 04

Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?

Jan 25
Is Pro-Dex (NASDAQ:PDEX) A Risky Investment?

What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?

Jan 11
What Is The Ownership Structure Like For Pro-Dex, Inc. (NASDAQ:PDEX)?

How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?

Dec 28
How Much Are Pro-Dex, Inc. (NASDAQ:PDEX) Insiders Taking Off The Table?

With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting

Dec 14
With EPS Growth And More, Pro-Dex (NASDAQ:PDEX) Is Interesting

What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Nov 30
What Is Pro-Dex, Inc.'s (NASDAQ:PDEX) Share Price Doing?

Rendement voor aandeelhouders

PDEXUS Medical EquipmentUS Markt
7D17.8%-0.6%-0.4%
1Y100.3%22.6%34.1%

Rendement versus industrie: PDEX overtrof de US Medical Equipment industrie, die het afgelopen jaar een rendement 22.6 % opleverde.

Rendement versus markt: PDEX overtrof de US markt, die het afgelopen jaar een rendement opleverde van 34.1 %.

Prijsvolatiliteit

Is PDEX's price volatile compared to industry and market?
PDEX volatility
PDEX Average Weekly Movement9.3%
Medical Equipment Industry Average Movement8.5%
Market Average Movement6.4%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: De aandelenkoers van PDEX is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 9% ) van PDEX is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1978147Rick Van Kirkwww.pro-dex.com

Pro-Dex, Inc. ontwerpt, ontwikkelt, produceert en verkoopt wereldwijd chirurgische instrumenten voor fabrikanten van medische apparatuur. Het bedrijf biedt autoclaveerbare, batterijgevoede en elektrische, en multifunctionele chirurgische drivers en scheerapparaten die voornamelijk worden gebruikt in de orthopedische, thorax- en craniomaxillofaciale markten. Het bedrijf levert ook adviesdiensten op het gebied van techniek, kwaliteit en regelgeving en produceert en verkoopt roterende luchtmotoren aan verschillende industrieën.

Pro-Dex, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Pro-Dex zich tot de beurswaarde?
PDEX fundamentele statistieken
MarktkapitalisatieUS$100.24m
Inkomsten(TTM)US$2.13m
Inkomsten(TTM)US$53.84m

49.5x

Koers/Winstverhouding

2.0x

P/S-verhouding

Is PDEX overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
PDEX resultatenrekening (TTM)
InkomstenUS$53.84m
Kosten van inkomstenUS$39.29m
BrutowinstUS$14.55m
Overige uitgavenUS$12.42m
InkomstenUS$2.13m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)0.63
Brutomarge27.02%
Nettowinstmarge3.95%
Schuld/Eigen Vermogen Verhouding38.6%

Hoe presteerde PDEX op de lange termijn?

Bekijk historische prestaties en vergelijking